Advertisement
U.S. Markets open in 5 hrs 55 mins

Cardiff Oncology, Inc. (CRDF)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
3.8100+0.1200 (+3.25%)
At close: 04:00PM EST
3.9100 +0.10 (+2.62%)
After hours: 07:49PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
665
488
386
359
366
Cost of Revenue
0
-
-
-
-
Gross Profit
244.632
-
-
-
-
Operating Expense
45,295
45,900
40,288
29,214
19,452
Operating Income
-44,630
-45,412
-39,902
-28,855
-19,086
Net Non Operating Interest Income Expense
3,807
4,069
1,581
264
88
Other Income Expense
-34
-98
-383
300
-309
Pretax Income
-40,857
-41,441
-38,704
-28,291
-19,307
Net Income Common Stockholders
-40,881
-41,465
-38,728
-28,315
-22,598
Diluted NI Available to Com Stockholders
-40,881
-41,465
-38,728
-28,315
-22,598
Basic EPS
-0.92
-0.93
-0.89
-0.73
-1.08
Diluted EPS
-0.92
-0.93
-0.89
-0.73
-1.08
Basic Average Shares
44,640
44,677
43,600
39,030
20,875
Diluted Average Shares
44,640
44,677
43,600
39,030
20,875
Total Operating Income as Reported
-44,630
-45,412
-39,902
-28,855
-19,086
Total Expenses
45,295
45,900
40,288
29,214
19,452
Net Income from Continuing & Discontinued Operation
-40,857
-41,441
-38,704
-28,291
-19,307
Normalized Income
-40,857
-41,441
-38,704
-28,576
-19,026
Interest Income
3,807
4,069
1,581
264
90
Interest Expense
-
-
-
0
2
Net Interest Income
3,807
4,069
1,581
264
88
EBIT
-44,630
-45,412
-39,902
-28,855
-19,305
EBITDA
-44,213
-45,014
-39,666
-28,404
-18,839
Reconciled Cost of Revenue
0
-
-
-
-
Reconciled Depreciation
417
398
236
451
466
Net Income from Continuing Operation Net Minority Interest
-40,857
-41,441
-38,704
-28,291
-19,307
Total Unusual Items Excluding Goodwill
-
-
-
285
-281
Total Unusual Items
-
-
-
285
-281
Normalized EBITDA
-44,213
-45,014
-39,666
-28,689
-18,558
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0